The Bioscience Managers team has over 30+ years international funds management experience, delivering annual IRR’s over 22-44%. With investor returns as our primary consideration, our investment model is designed to offer investors access to the life sciences and healthcare arena in a way which manages risk and return for the investors’ benefit.
Read more-
Bioscience Managers Announces First Close on New Healthcare Fund
• Top Decile Fund Manager announces first close on second fund
Read more
• First closing at A$55m supported by Australian institutions
• IOOF provides $45m cornerstone
• Focused on clinical stage healthcare and life sciences firms
• First investment $3m into ASX Listed Avita (ASX.AVH)